Product Description: 8-Azaadenosine is a potent ADAR1 inhibitor and an A-to-I editing inhibitor. 8-Azaadenosine blocks RNA editing and inhibits proliferation, 3D growth, invasion, and migration in thyroid cancer cells[1][2].
Formula: C9H12N6O4
References: [1]Maria Anna Zipeto, et al. ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis. Cell Stem Cell. 2016 Aug 4;19(2):177-191./[2]Julia Ramírez-Moya, et al. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity. Oncogene. 2020 Apr;39(18):3738-3753.
CAS Number: 10299-44-2
Molecular Weight: 268.23
Compound Purity: 99.97
Research Area: Cancer; Inflammation/Immunology
Solubility: DMSO : 250 mg/mL (ultrasonic)/H2O : 3.33 mg/mL (ultrasonic;warming;heat to 60°C)
Target: Adenosine Deaminase